Here are the key points about neuropsychiatric symptoms in Parkinson’s disease (PD):
1. Prevalence and common symptoms:
– Neuropsychiatric symptoms are very common in PD, affecting up to 89% of patients at some point[1][7].
– The most frequent symptoms are depression, anxiety, apathy, hallucinations, and impulse control disorders[1][2][5].
– Depression affects approximately 30-40% of PD patients[6].
– Anxiety affects up to 40% of PD patients[6].
– Apathy prevalence ranges from 17-70% depending on diagnostic criteria used[7].
2. Impact:
– Neuropsychiatric symptoms significantly impact quality of life, daily functioning, and caregiver burden[1][9].
– They are associated with increased risk of nursing home admission[1].
– Depression and anxiety scores are closely linked to patient-perceived health status[6].
3. Characteristics:
– Symptoms can occur at all stages of PD, even in early/prodromal phases[3][7].
– Depression and anxiety can be “off-period” related phenomena, fluctuating with motor symptoms[6].
– Apathy is characterized by emotional indifference, reduced activity/interest, and lack of concern for others[7].
4. Underlying mechanisms:
– The pathophysiology is likely multifactorial, involving dopaminergic, serotonergic, noradrenergic and cholinergic systems[6][8].
– Neuroimaging studies show alterations in various brain regions/networks for different symptoms[3][8].
5. Diagnosis and assessment:
– Diagnosis can be challenging due to symptom overlap with PD motor symptoms[6][7].
– Validated assessment scales are now available for most symptoms[2].
6. Management:
– Treatment involves both pharmacological and non-pharmacological approaches[2].
– Balancing dopaminergic therapy is important, as it can improve some symptoms but exacerbate others[2].
7. Prognosis:
– Psychiatric symptoms like psychosis, depression and apathy are associated with poorer outcomes including cognitive decline and disease progression[8].
In summary, neuropsychiatric symptoms are a core feature of PD that significantly impact patients’ lives. They require careful assessment and management as part of comprehensive PD care.
Citations:
[1] https://jnnp.bmj.com/content/78/1/36
[2] https://link.springer.com/article/10.1007/s40263-018-0540-6
[3] https://www.nature.com/articles/s41398-024-03070-z
[4] https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00025/full
[5] https://pmc.ncbi.nlm.nih.gov/articles/PMC9110237/
[6] https://pmc.ncbi.nlm.nih.gov/articles/PMC2787875/
[7] https://www.cambridge.org/core/journals/bjpsych-advances/article/neuropsychiatric-symptoms-in-parkinsons-disease-aetiology-diagnosis-and-treatment/E8BBA87713D9DC93E65D7AB1929CC00B
[8] https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00036-X/fulltext
[9] https://www.mdpi.com/2076-3425/12/1/89
